While life sciences M&A activity surges in today’s markets, the shift in regulatory enforcement priorities, constant innovation in technology, ...

With their collective track record of active leadership, the new board members will help direct eLife in its mission to ...

Third highest annual cash flow from operations of $1.43 billion- Repurchased record $1.09 billion of common stock in 2024; outstanding shares ...